Beckman Coulter Life Sciences

Beckman Coulter Diagnostics is a global leader in clinical diagnostics and biomedical testing. The company develops, manufactures, and markets innovative products that simplify and automate laboratory procedures, supporting healthcare professionals in disease diagnosis, treatment decisions, and patient monitoring. Founded in 1935, it has expanded through key acquisitions and is now a subsidiary of Danaher Corporation, with headquarters in Brea, California. The company focuses on medical devices and diagnostics, emphasizing efficiency and clinical confidence. It offers a wide range of laboratory testing instruments and solutions, including clinical chemistry systems, immunoassay systems, and hematology tools. Beckman Coulter Diagnostics also provides life sciences tools and in vitro diagnostic systems, enabling precise chemical analysis and biological testing. Its products are utilized by healthcare professionals and laboratories worldwide, contributing to improved health outcomes, such as enhanced prenatal screening in partnership with the Chinese government. The company generates annual revenue of approximately $2.9 billion.